Type 2 inflammation is a common feature in patients with asthma, characterized by the activation of group ILC2s in the lungs in response to inhaled allergens, particularly through the production of alarmins such as IL-33 by epithelial cells (56). This evidence concerns the gene IL33 and asthma.